retatrutide peptid 20mg Peptides Pure lab peptides Retatrutide 20mg

After 56 weeks of treatment, the weight loss was achieved in 1.6% versus 5.1% and 10.9% in the placebo, phentermine/topiramate (3.75/23 mg) and phentermine/topiramate (15/92 mg), respectively (52)

It activates three receptors simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon

You are never pushed to increase faster than youre ready, and your long-term dose is chosen based on what works best for your body, not a preset target

GLP-1 medications Let's be straightforward: lifestyle changes alone cannot replicate the weight loss effects of GLP-1 medications

Both drugs contain the same active ingredient and are classified as glucagon-like peptide-1 (GLP-1) receptor agonists

Here is why that matters